z-logo
open-access-imgOpen Access
Re-Profiling of US-FDA Approved Drugs for COVID-19 by In-silico Studies
Author(s) -
Akash Anandrao Parab,
Dr Gaganjyot Kaur,
Abhishek Sharma,
Gursewak Bhuller,
Sharvari Chitnis,
Ankit Chindaliya,
Mayur Weta
Publication year - 2021
Publication title -
journal of bioinformatics and systems biology
Language(s) - English
Resource type - Journals
ISSN - 2688-5107
DOI - 10.26502/jbsb.5107021
Subject(s) - drug repositioning , in silico , drug , repurposing , medicine , pharmacology , virtual screening , approved drug , covid-19 , computational biology , drug discovery , disease , infectious disease (medical specialty) , bioinformatics , biology , gene , ecology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom